» Articles » PMID: 23406368

Reductions in Non-medical Prescription Opioid Use Among Adults in Ontario, Canada: Are Recent Policy Interventions Working?

Overview
Publisher Biomed Central
Specialty Psychiatry
Date 2013 Feb 15
PMID 23406368
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Non-medical prescription opioid use (NMPOU) and prescription opioid (PO) related harms have become major substance use and public health problems in North America, the region with the world's highest PO use levels. In Ontario, Canada's most populous province, NMPOU rates, PO-related treatment admissions and accidental mortality have risen sharply in recent years. A series of recent policy interventions from governmental and non-governmental entities to stem PO-related problems have been implemented since 2010.

Findings: We compared the prevalence of NMPOU in the Ontario general adult population (18 years+) in 2010 and 2011 based on data from the 'Centre for Addiction and Mental Health (CAMH) Monitor' (CM), a long-standing annual telephone interview-based representative population survey of substance use and health indicators. While 'any PO use' (in past year) changed non-significantly from 26.6% to 23.9% (Chi2 = 2.511; df = 1; p =  0.113), NMPOU decreased significantly from 7.7% to 4.0% (Chi2 = 14.786; df = 1; p < 0.001) between 2010 and 2011. Over-time changes varied by age group but not by sex.

Conclusions: The observed substantial decrease in NMPOU in the Ontario adult population could be related to recent policy interventions, alongside extensive media reporting, focusing on NMPOU and PO-related harms, and may mean that these interventions have shown initial effects. However, other casual factors could have been involved. Thus, it is necessary to systematically examine whether the observed changes will be sustained, and whether other key PO-related harm indicators (e.g., treatment admissions, accidental mortality) change correspondingly in order to more systematically assess the impact of the policy measures.

Citing Articles

An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada.

Cheng T, Small W, Dong H, Nosova E, Hayashi K, DeBeck K Subst Abuse Treat Prev Policy. 2018; 13(1):41.

PMID: 30482215 PMC: 6260714. DOI: 10.1186/s13011-018-0180-3.


Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.

Martins S, Segura L, Santaella-Tenorio J, Perlmutter A, Fenton M, Cerda M Addict Behav. 2016; 65:236-241.

PMID: 27614657 PMC: 5140701. DOI: 10.1016/j.addbeh.2016.08.033.


State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review.

Beaudoin F, Banerjee G, Mello M J Opioid Manag. 2016; 12(2):109-18.

PMID: 27194195 PMC: 9897022. DOI: 10.5055/jom.2016.0322.


Denial of prescription analgesia among people who inject drugs in a Canadian setting.

Voon P, Callon C, Nguyen P, Dobrer S, Montaner J, Wood E Drug Alcohol Rev. 2014; 34(2):221-8.

PMID: 25521168 PMC: 4657858. DOI: 10.1111/dar.12226.


Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later.

Fischer B, Gooch J, Goldman B, Kurdyak P, Rehm J Can J Public Health. 2014; 105(2):e146-9.

PMID: 24886852 PMC: 6972194. DOI: 10.17269/cjph.105.4143.


References
1.
Passik S, Kirsh K . The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol. 2008; 16(5):400-4. DOI: 10.1037/a0013634. View

2.
Fischer B, Argento E . Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012; 15(3 Suppl):ES191-203. View

3.
Gilson A, Kreis P . The burden of the nonmedical use of prescription opioid analgesics. Pain Med. 2009; 10 Suppl 2:S89-100. DOI: 10.1111/j.1526-4637.2009.00668.x. View

4.
Fischer B, Nakamura N, Rush B, Rehm J, Urbanoski K . Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug Alcohol Depend. 2010; 109(1-3):257-60. DOI: 10.1016/j.drugalcdep.2010.02.001. View

5.
Dhalla I, Mamdani M, Sivilotti M, Kopp A, Qureshi O, Juurlink D . Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009; 181(12):891-6. PMC: 2789126. DOI: 10.1503/cmaj.090784. View